glp-1 success Surgeon sees surge in body lifts following weight loss Semaglutide Alpharetta - Thrive Medical

Chen TY, Hiyama A, Muramatsu M, Hinotsu A

Latin America held a 3% share of the market in 2025 and is expected to grow at a significant CAGR of 14% during the projection period, driven by GLP-1 medications that are driving structural health and economic shifts across Latin America by curbing surging obesity and type-2 diabetes rates, spurring vast biopharma investments, and fundamentally changing consumer habits in the fast-moving consumer goods sector

Johnson JA, El Barbary A, Kornguth SE, Brugge JF, Siegel FL

This is the first threshold of enhancement, he said

But if youre looking for non-injectable GLP-1s or more intensive coaching, other clinics may be a better match